Search all trials

Find therapies in clinical trials near you – page 6

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 962
countries: 28
conditions: 2 101

3 962 trials recruiting28 European countries2 101 conditions coveredUpdated today

Quick filters

Medullary thyroid cancer

Not recruiting

Registered drug

Comparison of two doses of cabozantinib (60 mg vs 140 mg) in patients with progressive metastatic medullary thyroid cancer

Registered drug

Croatia

Participants:18–64 years · 65+ years
Substances:Cabozantinib

Contact Research Centre

Metastatic malignant melanoma

Not recruiting

Registered drugNo placebo

Study Comparing ABP 206 and Nivolumab for Patients with Unresectable or Metastatic Melanoma

Registered drugNo placebo

Croatia

Participants:18–64 years · 65+ years
Substances:Nivolumab

Contact Research Centre

Multiple sclerosis relapse

Not recruiting

Registered drugNo placebo

Study on Long-Term Safety and Effectiveness of Ofatumumab for Patients with Relapsing Multiple Sclerosis

Registered drugNo placebo

Croatia

Participants:18–64 years
Substances:Ofatumumab

Contact Research Centre

Psoriatic arthropathy

Not recruiting

Investigational

Study on the Effects and Safety of Guselkumab for Patients with Active Psoriatic Arthritis

Investigational

Croatia

Participants:18–64 years · 65+ years
Substances:Guselkumab

Contact Research Centre

Diffuse large B-cell lymphoma

Not recruiting

Registered drugNo placebo

Study Comparing Epcoritamab and Lenalidomide with a Drug Combination for Adults with Relapsed or Refractory Diffuse Large B-Cell Lymphoma

Registered drugNo placebo

Croatia

Participants:18–64 years · 65+ years
Substances:Epcoritamab

Contact Research Centre

IgA nephropathy

Not recruiting

Registered drugNo placebo

Study on the Effectiveness and Safety of Sparsentan and Dapagliflozin for Patients with Immunoglobulin A Nephropathy (IgAN)

Registered drugNo placebo

Croatia

Participants:18–64 years · 65+ years
Substances:Dapagliflozin

Contact Research Centre

Squamous cell carcinoma of head and neck

Not recruiting

Registered drugNo placebo

Study of petosemtamab with pembrolizumab compared to pembrolizumab alone in patients with head and neck cancer who have not received previous treatment for advanced disease

Registered drugNo placebo

Croatia

Participants:18–64 years · 65+ years
Substances:Pembrolizumab

Contact Research Centre

Neovascular age-related macular degeneration

Not recruiting

Registered drug

Study of OPT-302 and Aflibercept for Patients with Wet Age-related Macular Degeneration

Registered drug

Croatia

Participants:18–64 years · 65+ years
Substances:Aflibercept

Contact Research Centre

Crohn's disease

Not recruiting

Investigational

Study on the Effects of Etrasimod Arginine for Patients with Moderate to Severe Crohn's Disease

Investigational

Croatia

Participants:18–64 years · 65+ years
Substances:Etrasimod Arginine

Contact Research Centre

Hidradenitis

Not recruiting

Investigational

Study of Lutikizumab compared to placebo in adults and adolescents (age 12 and older) with moderate to severe Hidradenitis Suppurativa

Investigational

Croatia

Participants:0–17 years · 18–64 years · 65+ years
Substances:Lutikizumab

Contact Research Centre

Primary progressive multiple sclerosis

Not recruiting

Registered drug

Study on the Effectiveness and Safety of Ocrelizumab for Adults with Primary Progressive Multiple Sclerosis

Registered drug

Croatia

Participants:18–64 years
Substances:Ocrelizumab

Contact Research Centre

Hepatic cirrhosis

Not recruiting

Registered drugNo placebo

Study on the Effects of Human Serum Albumin on Survival in Patients with Severe Acute-On-Chronic Liver Failure

Registered drugNo placebo

Croatia

Participants:18–64 years · 65+ years
Substances:Human Serum Albumin

Contact Research Centre

Find therapies in clinical trials near you – page 6

85 trials match your criteria

Medullary thyroid cancer

Comparison of two doses of cabozantinib (60 mg vs 140 mg) in patients with progressive metastatic medullary thyroid cancer

Metastatic malignant melanoma

Study Comparing ABP 206 and Nivolumab for Patients with Unresectable or Metastatic Melanoma

Multiple sclerosis relapse

Study on Long-Term Safety and Effectiveness of Ofatumumab for Patients with Relapsing Multiple Sclerosis

Psoriatic arthropathy

Study on the Effects and Safety of Guselkumab for Patients with Active Psoriatic Arthritis

Diffuse large B-cell lymphoma

Study Comparing Epcoritamab and Lenalidomide with a Drug Combination for Adults with Relapsed or Refractory Diffuse Large B-Cell Lymphoma

IgA nephropathy

Study on the Effectiveness and Safety of Sparsentan and Dapagliflozin for Patients with Immunoglobulin A Nephropathy (IgAN)

Squamous cell carcinoma of head and neck

Study of petosemtamab with pembrolizumab compared to pembrolizumab alone in patients with head and neck cancer who have not received previous treatment for advanced disease

Neovascular age-related macular degeneration

Study of OPT-302 and Aflibercept for Patients with Wet Age-related Macular Degeneration

Crohn's disease

Study on the Effects of Etrasimod Arginine for Patients with Moderate to Severe Crohn's Disease

Hidradenitis

Study of Lutikizumab compared to placebo in adults and adolescents (age 12 and older) with moderate to severe Hidradenitis Suppurativa

Primary progressive multiple sclerosis

Study on the Effectiveness and Safety of Ocrelizumab for Adults with Primary Progressive Multiple Sclerosis

Hepatic cirrhosis

Study on the Effects of Human Serum Albumin on Survival in Patients with Severe Acute-On-Chronic Liver Failure

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.